Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo
Authors
Minjun Meng
Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, China
Qiaolu Yang
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Zhong Ouyang
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Qingmo Yang
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Xinyi Wu
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Yufan Huang
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Yonghui Su
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Shuanglong Chen
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Wenlin Chen
Department of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Language: English
Page range: 75 - 90
Accepted on: Jul 31, 2022
Published on: Jan 24, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2023 Minjun Meng, Qiaolu Yang, Zhong Ouyang, Qingmo Yang, Xinyi Wu, Yufan Huang, Yonghui Su, Shuanglong Chen, Wenlin Chen, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.